ABVC BioPharma, Inc.
ABVC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6,888 | $5,030 | $19,788 | $84,920 |
| - Cash | $248 | $60 | $85 | $5,829 |
| + Debt | $3,195 | $2,278 | $3,055 | $3,112 |
| Enterprise Value | $9,834 | $7,248 | $22,757 | $82,203 |
| Revenue | $510 | $152 | $970 | $356 |
| % Growth | 234.3% | -84.3% | 172.6% | – |
| Gross Profit | $509 | -$150 | $683 | $351 |
| % Margin | 99.9% | -98.1% | 70.5% | 98.6% |
| EBITDA | -$4,343 | -$6,331 | -$15,197 | -$10,972 |
| % Margin | -852.2% | -4,153.2% | -1,567% | -3,083.7% |
| Net Income | -$4,903 | -$7,788 | -$16,423 | -$12,839 |
| % Margin | -962.1% | -5,109.3% | -1,693.5% | -3,608.5% |
| EPS Diluted | -0.42 | -1.8 | -5.2 | -5.1 |
| % Growth | 76.7% | 65.4% | -2% | – |
| Operating Cash Flow | -$1,809 | -$4,187 | -$7,398 | -$7,598 |
| Capital Expenditures | $0 | -$21 | -$120 | -$18 |
| Free Cash Flow | -$1,809 | -$4,208 | -$7,518 | -$7,615 |